Literature DB >> 10714238

The EGF domain: requirements for binding to receptors of the ErbB family.

E J Van Zoelen1, C Stortelers, A E Lenferink, M L Van de Poll.   

Abstract

Epidermal growth factor (EGF) has been the prototype growth-stimulating peptide for many years. It has a characteristic structure with three disulfide bridges, which is essential for its activity. However, many other proteins, including both growth factors and proteins with unrelated functions, have similar EGF-like domains. This indicates that besides a characteristic conformation provided by the EGF-like domain, specific amino acids are required to provide specificity in protein functioning. Currently, more than 10 different growth factors with an EGF-like domain have been characterized which all exert their action by binding to the four members of the erbB family of receptors. In this review, studies are described on the structure-function relationship of these EGF-like growth factor molecules in an attempt to analyze the individual amino acids that determine their binding specificity to the individual members of the erbB family.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714238     DOI: 10.1016/s0083-6729(00)59005-0

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  9 in total

Review 1.  Neuregulin signaling via erbB receptor assemblies in the nervous system.

Authors:  Sean Murphy; Randy Krainock; Muly Tham
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

2.  Structural features of the lysosomal hydrolase mannose 6-phosphate uncovering enzyme.

Authors:  Yuqiang Wei; Ten-Yang Yen; Jian Cai; John O Trent; William M Pierce; William W Young
Journal:  Glycoconj J       Date:  2005-02       Impact factor: 2.916

3.  Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways.

Authors:  M Massimiani; L Vecchione; D Piccirilli; P Spitalieri; F Amati; S Salvi; S Ferrazzani; H Stuhlmann; L Campagnolo
Journal:  Mol Hum Reprod       Date:  2015-02-09       Impact factor: 4.025

Review 4.  Structure, evolution, and biology of the MUC4 mucin.

Authors:  Pallavi Chaturvedi; Ajay P Singh; Surinder K Batra
Journal:  FASEB J       Date:  2007-11-16       Impact factor: 5.191

5.  Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands.

Authors:  Moshit Lindzen; Sara Lavi; Orith Leitner; Yosef Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

6.  Chondrocyte expressed protein-68 (CEP-68), a novel human marker gene for cultured chondrocytes.

Authors:  E Steck; K Benz; H Lorenz; M Loew; T Gress; W Richter
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

7.  An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.

Authors:  S Carvalho; M Lindzen; M Lauriola; N Shirazi; S Sinha; A Abdul-Hai; K Levanon; J Korach; I Barshack; Y Cohen; A Onn; G Mills; Y Yarden
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

8.  Identification and Characterization of Novel Matrix-Derived Bioactive Peptides: A Role for Collagenase from Santyl® Ointment in Post-Debridement Wound Healing?

Authors:  Anthony R Sheets; Tatiana N Demidova-Rice; Lei Shi; Vincent Ronfard; Komel V Grover; Ira M Herman
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

9.  Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons.

Authors:  Thomas Müller; Stephanie Braud; René Jüttner; Birgit C Voigt; Katharina Paulick; Maria E Sheean; Constantin Klisch; Dilansu Gueneykaya; Fritz G Rathjen; Jörg Rp Geiger; James Fa Poulet; Carmen Birchmeier
Journal:  EMBO J       Date:  2018-07-26       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.